Plaque rupture, lysophosphatidic acid, and thrombosis.
Spector
Arthur A
AA
D001161:Arteriosclerosis / Q000150:complications* / Q000378:metabolism* / Q000473:pathology; D002339:Carotid Arteries / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D003328:Coronary Thrombosis / Q000209:etiology* / Q000517:prevention & control*; D011756:Diphosphates / Q000494:pharmacology; D016894:Endarterectomy, Carotid; D005990:Glycerol / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism; D008246:Lysophospholipids / Q000378:metabolism* / Q000494:pharmacology; D010743:Phospholipids / Q000378:metabolism; D015539:Platelet Activation / Q000187:drug effects; D011956:Receptors, Cell Surface / Q000037:antagonists & inhibitors; D043562:Receptors, G-Protein-Coupled; D049368:Receptors, Lysophosphatidic Acid
D011756:Diphosphates; D008077:Lipoproteins, LDL; D008246:Lysophospholipids; D010743:Phospholipids; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D049368:Receptors, Lysophosphatidic Acid; C408642:diacylglycerol pyrophosphate; C099252:oxidized low density lipoprotein; D005990:Glycerol